CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings Prognostic implications of ischemia with nonobstructive coronary arteries (INOCA): Understanding risks for improving treatment Nicotine promotes vascular calcification via intracellular Ca21-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells Lysed Erythrocyte Membranes Promote Vascular Calcification: Possible Role of Erythrocyte-Derived Nitric Oxide Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial m6A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label,blinded-outcome,randomised trial

Guideline2018 Sep 25;138(13):e415-e418.

JOURNAL:Circulation. Article Link

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Al-Khatib SM, Stevenson WG, Ackerman MJ et al. Keywords: AHA Scientific Statements; CT imaging; ECG; MR imaging; acute coronary syndrome; ambulatory ECG monitoring; antiarrhythmic drug therapy; arrhythmogenic cardiomyopathy; athletes; cardiac electrophysiology; cardiac resynchronization therapy; cardiomyopathy; catheter ablation; congenital heart disease; echocardiography; electrophysiological testing; genetic arrhythmias; guidelines; heart failure; imaging; implantable and external cardioverter devices; implantable cardioverter-defibrillator; medication-induced arrhythmias; myocardial infarction; premature ventricular beats; resuscitation; sarcoidosis; specific pathology (eg, congenital heart disease, myocarditis, renal failure); stable coronary artery disease; sudden cardiac arrest; sudden cardiac death; torsades de pointes; ventricular fibrillation; ventricular tachycardia

FULL TEXT PDF